Healthcare Capital in an 8-K filing said it adjourned the shareholder meeting yesterday without conducting any business. The SPAC’s shareholders were scheduled to vote on the proposed merger with oncology therapy company Alpha Tau.
The SPAC in the filing said adjourning until Friday would give it more time to meet the requirements to close the deal, which has a minimum cash condition of $225 million.
As announced in July last year, the transaction is expected to provide up to $367 million in gross proceeds, including up to $275 million of cash held in Healthcare Capital’s trust account and a $92 million PIPE. Read more.
